LTRN NASDAQ
Lantern Pharma Inc.
1W: -27.3%
1M: -54.1%
3M: -77.5%
YTD: -71.5%
1Y: -78.5%
3Y: -76.4%
5Y: -92.7%
$0.86
-0.14 (-13.99%)
Weekly Expected Move ±14.2%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-11-24
Earliest Filing
2025-07-03
Latest Filing
investor: 2
partner: 1
Counterparties (Filed by LTRN)
3 relationshipsCompanies named in LTRN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ThinkEquity LLC | — | partner | Agent for the ATM Sales Agreement | 2025-07-03 | View |
| Bios Fund I QP, LP | — | investor | Sold 145,348 shares of common stock to Lantern Pharma Inc. for $499,997.12 | 2023-11-24 | View |
| Bios Fund I, LP | — | investor | Sold 145,348 shares of common stock to Lantern Pharma Inc. for $499,997.12 | 2023-11-24 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Delisting Notice | View | |
| 2026-09-30 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-09-24 | Regulation FD; Exhibits | View | |
| 2026-09-23 | Regulation FD; Exhibits | View | |
| 2026-08-14 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-03 | Regulation FD; Exhibits | View | |
| 2026-06-02 | Regulation FD; Exhibits | View | |
| 2026-05-15 | Earnings Release; Exhibits | View | |
| 2026-05-14 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-04-10 | Regulation FD; Exhibits | View | |
| 2026-03-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-01-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-29 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-07-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-15 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-10 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR